Showing results (1-10 of 274) with videos related to
Sort By:
Pageof 28
Expert Opinion on Pharmacotherapy|December 6, 2025
Lipoprotein(a) - treatments in developmentBrian Tomlinson, Chak Fun LawJournal of Clinical Medicine|September 23, 2022
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 PatientsUt-Sam Lao, Chak-Fun Law, Daniel T Baptista-Hon, et al.Current Opinion in Investigational Drugs (London, England : 2000)|November 8, 2006
Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factorBrian TomlinsonCurrent Opinion in Investigational Drugs (London, England : 2000)|November 30, 2005
Febuxostat (Teijin/Ipsen/TAP)Brian TomlinsonExpert Opinion on Biological Therapy|December 13, 2024
An up-to-date review of emerging biologic therapies for hypercholesterolemiaBrian TomlinsonExpert Opinion on Pharmacotherapy|March 5, 2026
Pharmacological management of elevated LDL in patients with hypercholesterolaemia and mixed dyslipidaemiaBrian TomlinsonExpert Opinion on Investigational Drugs|February 27, 2009
Tesamorelin, a human growth hormone releasing factor analogueYing Wang, Brian TomlinsonBiologics : Targets & Therapy|November 3, 2025
Antibody-Based Therapeutics for HypercholesterolemiaBrian Tomlinson, Paul ChanExpert Opinion on Drug Metabolism & Toxicology|April 10, 2024
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an updateBrian Tomlinson, Paul ChanPageof 28